Screener
Gyre Therapeutics, Inc. GYRE Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Gyre Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Gyre Therapeutics, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 5:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-340448
FAQ
- What is Gyre Therapeutics, Inc.'s asset turnover?
- Gyre Therapeutics, Inc. (GYRE) reported asset turnover of 0.7× in Q2 2026.
- How has Gyre Therapeutics, Inc.'s asset turnover changed year-over-year?
- Gyre Therapeutics, Inc.'s asset turnover decreased by 11.7% year-over-year, from 0.8× to 0.7×.
- What is the long-term trend for Gyre Therapeutics, Inc.'s asset turnover?
- Over 4 years (2020 to 2025), Gyre Therapeutics, Inc.'s asset turnover has grown at a 33.7% compound annual growth rate (CAGR), from 0.2× to 0.7×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Gyre Therapeutics, Inc.'s asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude